Healthcare Services

Lupus Nephritis Market Analysis Reflecting Expansion Trends And Industry Performance

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Size Is Forecasted For The Lupus Nephritis Market By 2030 Based On Its 2026 Value?

The lupus nephritis market size has shown significant expansion in recent years. It is anticipated to increase from $2.08 billion in 2025 to $2.24 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.7%. This growth in the historic period is attributable to the increasing prevalence of systemic lupus erythematosus, advancements in kidney biopsy and diagnostic practices, the widespread use of corticosteroids in treatment, the expansion of hospital-based nephrology care, and heightened awareness of autoimmune kidney diseases.

The lupus nephritis market size is poised for significant expansion in the coming years. It is projected to reach $2.98 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.4%. This growth over the forecast period is propelled by factors such as increasing investment in biologic drug development, a greater emphasis on early intervention to prevent kidney failure, the rising adoption of combination therapy regimens, the expansion of specialty nephrology clinics, and increased healthcare spending dedicated to managing autoimmune diseases. Prominent trends anticipated during this period include a heightened focus on early diagnosis and disease monitoring, the growing uptake of immunosuppressive and biologic therapies, an increasing push towards personalized treatment approaches, the broadening of long-term disease management strategies, and rising awareness regarding autoimmune kidney complications.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22044&type=smp

Which Core Factors Are Supporting The Expansion Of The Lupus Nephritis Market?

The lupus nephritis market is anticipated to expand, driven by the rising occurrence of genetic predisposition. Genetic predisposition describes inherited genetic characteristics that elevate an individual’s susceptibility to specific diseases or conditions. This increase in genetic predisposition stems from elements like inheritance patterns, environmental factors, and genetic mutations. Its growing prevalence significantly contributes to the onset of lupus nephritis, highlighting how inherited genetic elements influence autoimmune conditions, especially those impacting renal function. For example, in October 2024, the UK-based national charity, the Cystic Fibrosis Trust, reported via its UK CF Registry that registered patients increased from 11,148 in 2022 to 11,318 in 2024, marking a 1.52% rise in individuals with cystic fibrosis (CF). Consequently, the rising incidence of genetic predisposition is fueling the expansion of the lupus nephritis market.

What Are The Core Segment Classifications In The Lupus Nephritis Market?

The lupus nephritis market covered in this report is segmented –

1) By Stage: Class 1, Class 2, Class 3, Other Stages

2) By Drug Class: Immunosuppressive Drugs, Corticosteroids, Biological Agents, Antimalarial Drugs

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Class 1: Asymptomatic Cases, Mild Proteinuria, Incidental Diagnosis

2) By Class 2: Mild Hematuria, Low-Grade Proteinuria, Minimal Immune Complex Deposition

3) By Class 3: Active Lesions, Chronic Sclerotic Lesions, Crescent Formation

4) By Other Stages: Class 4 (Diffuse Lupus Nephritis), Class 5 (Membranous Lupus Nephritis), Class 6 (Advanced Sclerotic Lupus Nephritis)

Which Trends Are Guiding The Development Of The Lupus Nephritis Market?

Major companies active in the lupus nephritis market are concentrating on developing sophisticated second-generation calcineurin inhibitors, aiming to elevate treatment efficacy and improve long-term kidney health outcomes for patients. These second-generation calcineurin inhibitors are applied in lupus nephritis to diminish inflammation and avert kidney damage through the modulation of immune responses. For instance, in September 2024, Aurinia Pharmaceuticals Inc., a Canada-based commercial-stage biopharmaceutical company, announced that LUPKYNIS (voclosporin) received approval from the Japanese Ministry of Health, Labour, and Welfare for the management of lupus nephritis. This authorization permits voclosporin to be administered in conjunction with mycophenolate mofetil (MMF), based on data from the AURORA Clinical Program which demonstrated its safety and effectiveness. The approval represents a crucial achievement in expanding therapeutic alternatives for lupus nephritis patients in Japan, leading to improved disease management and patient outcomes.

Who Are The Companies Shaping The Lupus Nephritis Market Landscape?

Major companies operating in the lupus nephritis market are F Hoffmann La Roche Ltd, Bristol Myers Squibb, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, AstraZeneca PLC, Pfizer Inc, Johnson and Johnson, Merck and Co Inc, Sanofi, AbbVie Inc, Bayer AG, Amgen Inc, UCB SA, Otsuka Pharmaceutical Co Ltd, Aurinia Pharmaceuticals Inc, RemeGen Co Ltd, Kezar Life Sciences, Equillium Inc, Kyverna Therapeutics Inc, Biogen Inc

Access The Complete Lupus Nephritis Market Report:

https://www.thebusinessresearchcompany.com/report/lupus-nephritis-global-market-report

Which Regional Market Leads The Lupus Nephritis Market?

Asia-Pacific was the largest region in the lupus nephritis market in 2025. The regions covered in the lupus nephritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Lupus Nephritis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=22044&type=smp

Browse Through More Reports Similar to the Global Lupus Nephritis Market 2026, By The Business Research Company

Cutaneous Lupus Erythematosus Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cutaneous-lupus-erythematosus-global-market-report

Lupus Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lupus-therapeutics-global-market-report

Kidney Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795